Jennifer Pugh
Family · Newark, DENPI 1164757118
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.0% of the total across 106 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 11.1% — the pattern of someone who eats at a lot of different presentations.
Across 106 payments — averaging $22.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$269
- Johnson & Johnson$223
- Genentech USA, Inc.$206
- Karyopharm Therapeutics Inc.$195
- Incyte Corporation$170
- Novartis$139
- plus $1K from 29 others
What the payments were for
- Food & beverage$2,32896%
- Education$964%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 12 | $269 |
| Johnson & Johnson | 7 | $223 |
| Genentech USA, Inc. | 10 | $206 |
| Karyopharm Therapeutics Inc. | 3 | $195 |
| Incyte Corporation | 8 | $170 |
| Novartis | 6 | $139 |
| Genmab U.S., Inc. | 4 | $104 |
| AbbVie | 5 | $99 |
| Merck | 4 | $90 |
| Sanofi | 5 | $89 |
| Amgen | 4 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $79 |
| E.r. Squibb & Sons, L.L.C. | 4 | $67 |
| Bayer | 3 | $59 |
| Secura Bio, Inc. | 1 | $54 |
| Pharmacosmos Therapeutics Inc. | 3 | $54 |
| AVEO Pharmaceuticals, Inc. | 3 | $53 |
| Astellas Pharma US Inc | 3 | $50 |
| Array Biopharma Inc | 2 | $32 |
| Pharmaessentia USA Corporation | 1 | $26 |
| Adaptive Biotechnologies Corporation | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Blueprint Medicines Corporation | 1 | $21 |
| Stemline Therapeutics Inc. | 1 | $21 |
| Kyowa Kirin, Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $20 |
| Pfizer | 1 | $20 |
| GSK | 1 | $19 |
| Morphosys, US Inc. | 1 | $19 |
| Mirati Therapeutics, Inc. | 1 | $16 |
| Deciphera Pharmaceuticals Inc. | 1 | $16 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| Gilead | 1 | $15 |
| Organon | 1 | $10 |
How this compares
$2,424 in reported general payments places this provider in the 80th percentile of 523 family providers in Delaware.
Other family in Newark
- Kathy GallagherNewark$53K
- Jodie DelesioNewark$50K
- Melanie HiesterNewark$9K
- Samatha GrayNewark$9K
- Byron MayNewark$8K
- Clare MatisNewark$8K
- Christine MazzolaNewark$7K
- Kelsey FrybergerNewark$7K
- Colleen AllenNewark$7K
- Mallory KowalskiNewark$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.